Background illustration for clinical trials search

Paid Clinical Trials Calgary

Discover 524 paid clinical trials in Calgary, . Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

IMPACT: IMplementation of Physical Activity for Children and Adolescents on Treatment

for
Pediatric Cancer, Pediatric Hematology
Location: Calgary, Edmonton
Sponsor: University of Calgary

Sex: All

Age: 5 - 18

Code: NCT04956133

Recruiting

Resistance Intensive Personal Training for Youth with Cerebral Palsy

for
Cerebral Palsy, Exercise, Resistance Training
Location: Calgary
Sponsor: University of Calgary

Sex: All

Age: 8 - 17

Code: NCT05731609

Recruiting

Pediatric Precision Laboratory Advanced Neuroblastoma Therapy

for
Neuroblastoma
Location: Calgary, Portland OR, Oakland CA, Minneapolis MN,
Sponsor: Giselle Sholler

Sex: All

Age: 0 - 22

Code: NCT02559778

Phase2, Recruiting

An Open-label Study to Assess Safety and Efficacy of SZC in Paediatric Patients With Hyperkalaemia

for
Hyperkalaemia
Location: Calgary, Cincinnati OH, Birmingham AL, Montreal,
Sponsor: AstraZeneca

Sex: All

Age: 0 - 18

Code: NCT03813407

Phase3, Recruiting

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

for
Hodgkin Lymphoma in Remission, Leukemia in Remission,
Location: Calgary, Spokane WA, Seattle WA, Portland OR,
Sponsor: Children's Oncology Group

Sex: All

Age: 0+

Code: NCT01790152

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

for
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma,
Location: Calgary, Edmonton, Spokane WA, Saskatoon, Vancouver,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 25

Code: NCT03959085

Phase3, Recruiting

Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma

for
Embryonal Rhabdomyosarcoma,
Location: Calgary, Edmonton, Spokane WA, Vancouver, Seattle WA,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 21

Code: NCT05304585

Phase3, Recruiting

Virtual Self-Management Program for JIA

for
Juvenile Idiopathic Arthritis
Location: Calgary
Sponsor: University of Calgary

Sex: All

Age: 12 - 17

Code: NCT06184100

Recruiting

A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

for
Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor,
Location: Calgary, Edmonton, Spokane WA, Vancouver, Seattle WA,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 30

Code: NCT04322318

Phase2, Recruiting

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

for
B-cell Acute Lymphoblastic Leukemia,
Location: Calgary, Portland OR, Salt Lake City UT, Fargo ND,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 0 - 25

Code: NCT06395103

Phase1, Phase2, Recruiting

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

for
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia,
Location: Calgary, Edmonton, Spokane WA, Vancouver, Seattle WA,
Sponsor: PedAL BCU, LLC

Sex: All

Age: 0 - 22

Code: NCT04726241

Phase1, Phase2, Recruiting

Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors

for
Childhood Extracranial Germ Cell Tumor,
Location: Calgary, Edmonton, Spokane WA, Missoula MT,
Sponsor: Children's Oncology Group

Sex: All

Age: 0+

Code: NCT03067181

Phase3, Recruiting

A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT

for
Central Nervous System Nongerminomatous Germ Cell Tumor,
Location: Calgary, Edmonton, Spokane WA, Vancouver, Seattle WA,
Sponsor: Children's Oncology Group

Sex: All

Age: 3 - 29

Code: NCT04684368

Phase2, Recruiting

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

for
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Location: Calgary, Edmonton, Spokane WA, Saskatoon, Vancouver,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 5 - 60

Code: NCT05675410

Phase3, Recruiting

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

for
Ganglioneuroblastoma, Nodular, Neuroblastoma
Location: Calgary, Edmonton, Spokane WA, Saskatoon, Vancouver,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0 - 30

Code: NCT06172296

Phase3, Recruiting

Project: Every Child for Younger Patients With Cancer

for
Adrenal Gland Pheochromocytoma, Carcinoma In Situ,
Location: Calgary, Edmonton, Spokane WA, Saskatoon, Vancouver,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 25

Code: NCT02402244

Recruiting

Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma

for
Metastatic Malignant Neoplasm in the Lung,
Location: Calgary, Edmonton, Spokane WA, Yakima WA, Seattle WA,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 50

Code: NCT05235165

Phase3, Recruiting

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

for
Acute Myeloid Leukemia
Location: Calgary, Edmonton, Spokane WA, Saskatoon, Vancouver,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 21

Code: NCT04293562

Phase3, Recruiting

DOnor Milk to REpair the Full-term Infant MIcrobiome in Infants Born Via Cesarean Section.

for
Microbial Colonization
Location: Calgary
Sponsor: University of Calgary

Sex: All

Age: 0+

Code: NCT06177184

Recruiting

Safety and Efficacy of Tarperprumig in Adult Participants With Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis

for
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Location: Calgary, Edmonton, Hamilton, Etobicoke, Toronto,
Sponsor: Alexion Pharmaceuticals, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07160608

Phase2, Recruiting